Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 6.03%. However, over the past six months, we’ve seen a weaker performance of 12.27%. The price of VXRT fallen by 75.50% over the last 30 days. And in the last five days, it has surged by 73.21%.
Vaxart Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $1.07 on 09/16/24, and the lowest price during the same period was recorded at $0.28 on 04/09/25.
52-week price history of VXRT Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Vaxart Inc’s current trading price is -34.39% away from its 52-week high, while its distance from the 52-week low is 146.32%. The stock’s price range for this period has been between $0.28 and $1.07. The Healthcare sector company’s shares saw a trading volume of about 28.64 million for the day, which was higher than the average daily volume of 3.61 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Vaxart Inc (VXRT) has experienced a quarterly rise of 30.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 160.27M and boasts a workforce of 115 employees.
How Moving Averages and Trading Volume Data Work Together
VXRT’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for VXRT stands at 0.45. Similarly, the long-term debt-to-equity ratio is also 0.31.
